Sun Pharma Biosimilar Infringes Galderma Oracea Patents
After wrestling with a late request to reconstrue a key term in the case, a Delaware federal judge has determined that Sun Pharmaceutical Industry Limited's biosimilar of Galderma's flagship drug Oracea...To view the full article, register now.
Already a subscriber? Click here to view full article